Elliptic Laboratories ASA

Total Valuation

Elliptic Laboratories ASA carries a market capitalization of 361.32M, placing it among publicly traded companies globally. Its enterprise value stands at 229.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Elliptic Laboratories ASA currently has 126.34M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 2.28, and the price-to-book ratio stands at 226.57.

Enterprise Valuation

On an enterprise value basis, Elliptic Laboratories ASA trades at an EV/EBITDA multiple of 172.56 and an EV/FCF ratio of 3.76. The EV/Sales ratio of 1.82 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 172.56 provides insight into valuation relative to core operating earnings.

Financial Position

Elliptic Laboratories ASA maintains a current ratio of 6.68, meaning it holds 6.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.50, indicating elevated leverage, while an interest coverage ratio of -1.38 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Elliptic Laboratories ASA has paid 89.91M in income taxes, reflecting an effective tax rate of 29.88.

Stock Price Statistics

Elliptic Laboratories ASA's stock has declined approximately -78.26748% over the past 52 weeks. The 50-day moving average sits at 3.06, while the 200-day moving average is 5.42.

Income Statement

Over the trailing twelve months, Elliptic Laboratories ASA generated 125.74M in revenue and converted that into -122.17M in net income, yielding earnings per share of -1.10. EBITDA reached -23.40M, while operating income came in at -23.40M.

Balance Sheet

Elliptic Laboratories ASA holds 71.18M in cash and equivalents against 14.38M in total debt, resulting in a net debt position of -71.18M. Total book value stands at 1.26M, with working capital of 140.95M providing operational flexibility.

Cash Flow

Elliptic Laboratories ASA produced -23.67M in operating cash flow over the past twelve months. After subtracting -20.26M in capital expenditures, free cash flow totaled -43.93M - equivalent to -0.43 per share.

Margins

Elliptic Laboratories ASA operates with a gross margin of 28.22, reflecting its pricing power and cost economics. The operating margin of -18.61 and net profit margin of -97.16 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Elliptic Laboratories ASA's most recent stock split took place on September 30, 2021 with a 1:10 split ratio.

Scores

Elliptic Laboratories ASA posts an Altman Z-Score of 6.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.